Based on ratings from 3 stock analysts, the Stericycle Inc stock price is expected to increase by 13.87% in 12 months. This is calculated by using the average 12-month stock price forecast for Stericycle Inc. The lowest target is $40.00 and the highest is $70.00. Please note analyst price targets are not guaranteed and could be missed completely.
About 3 Wall Street analysts have assignedSRCL 2 buy ratings, 0 hold ratings, and 1 sell ratings. This means that analysts expect Stericycle Inc to buy. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on SRCL. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
sean dodge RBC Capital | Buy | $58.0 | maintained | Jan 26, 2024 |
scott schneeberger Oppenheimer | Hold | None | maintained | Dec 14, 2023 |
john mazzoni Wells Fargo | Sell | $40.0 | rated | Dec 8, 2023 |
kevin steinke Barrington | Hold | None | maintained | Dec 7, 2023 |
michael e. hoffman Stifel Nicolaus | Buy | $70.0 | maintained | Nov 30, 2023 |
tobey sommer Truist Financial | Hold | $45.0 | maintained | Nov 2, 2023 |
david manthey Robert W. Baird | Hold | $50.0 | maintained | Nov 2, 2023 |
alexander leach Berenberg Bank | Hold | $46.0 | downgraded | May 12, 2022 |
jeffrey silber BMO Capital | Hold | $67.0 | rated | Nov 3, 2021 |
hamzah mazari Jefferies | Hold | $61.0 | rated | Aug 16, 2021 |
lawrence keusch Raymond James | Hold | None | maintained | May 5, 2021 |
isaac ro Goldman Sachs | Buy | $66.0 | upgraded | Mar 1, 2019 |
issac ro Goldman Sachs | Buy | $66.0 | upgraded | Mar 1, 2019 |
david keiser Northcoast Research | Hold | None | initiatedcoverage | Oct 13, 2018 |
logan purk Edward Jones | Hold | None | maintained | Sep 30, 2018 |
michael gibbs Raymond James | Hold | None | reiterated | Feb 22, 2018 |
jon windham UBS | Buy | $100.0 | initiatedcoverage | Apr 13, 2017 |
david windley Jefferies | Buy | $108.0 | reiterated | Nov 28, 2016 |
al kaschalk Wedbush | Hold | $85.0 | reiterated | Sep 22, 2016 |
edwin snyder Northcoast Research | Hold | None | downgraded | Sep 20, 2016 |
In 2023, SRCL generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that SRCL's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2019
Revenue From 2020
Revenue From 2021
Revenue From 2022
SPLK-USD
$154.42
TEAM-USD
$216.17
TXN-USD
$162.4
UPST-USD
$33.9
TXG-USD
$49.11
TWKS-USD
$4.41